CLOs on the Move

Digimarc

www.digimarc.com

 
Digimarc is a global leader in product digitization, based in Beaverton, Oregon. Founded in 1995, the company specializes in providing unique digital identities and cloud-based solutions that integrate with various applications and machines. Initially focused on digital watermarking technology, Digimarc has developed its flagship product, the Digimarc Barcode, which allows for the embedding of digital information into images and packaging without altering their visual appearance. This technology enhances tracking and data collection, making it ideal for packaging and marketing materials. The companys solutions support efficient tracking, authentication, and data management across multiple industries, including retail, consumer goods, and media. Digimarcs mission ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Psyop

Psyop is a multi-disciplinary studio specializing in emotive, visually stunning storytelling for the advertising, video gaming, broadcast and music video industries.

Western Fence Co

Western Fence Co is a Phoenix, AZ-based company in the Business Services sector.

The Headhunters

The Headhunters is a Vancouver, BC-based company in the Business Services sector.

Kracoe Szykula and Townsend Inc

Kracoe Szykula & Townsend Inc is a Troy, MI-based company in the Business Services sector.

CARB-X

CARB-X (Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator) is a global non-profit partnership dedicated to accelerating early development antibacterial R&D to address the rising global threat of drug-resistant bacteria. CARB-X is led by Boston University and its funding is provided by the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services; the Wellcome Trust, a global charity based in the UK; Germanys Federal Ministry of Education and Research (BMBF); the UK Department of Health and Social Cares Global Antimicrobial Resistance Innovation Fund (UK GAMRIF); the Bill & Melinda Gates Foundation, and with in-kind support from National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health (NIH) within the HHS. CARB-X is investing more than $500 million from 2016-2021 to support innovative antibiotics and other therapeutics, vaccines and rapid diagnostics. CARB-X supports the worlds largest and most innovative pipeline of preclinical products against drug-resistant infections. CARB-X focuses exclusively on high priority drug-resistant bacteria, especially Gram-negatives. CARB-X is headquartered at Boston University School of Law.